Second Opinion October 19, 2025
Christina Farr

A recently-published analysis shows that provider pricing in the commercial market is essentially random, and there’s no correlation to quality

Commercial negotiated rates vary wildly, but they don’t correlate with quality.

If you work in benefits, health plan design, or employer strategy, this new white paper from the Purchaser Business Group on Health (PBGH) is required reading. It pulls back the curtain on healthcare price transparency in the commercial market, revealing just how erratic and random U.S. healthcare price variation really is.

Unlike previous regional studies, this analysis spans multiple geographies and specialties, marrying transparency in coverage and hospital price transparency data with claims, quality, and safety measurements. The result: a disturbing portrait of how...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Healthcare System, Insurance, Patient / Consumer, Payer, Pricing / Spending, Provider, Survey / Study, Trends
Charted: Where measles is surging (again)
Addressing Costs Through Pricing And Coverage Policy
What Does It Take to Obtain Health Equity Accreditation? Process Explained
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
The 10 biggest health technology hazards, according to ECRI

Share Article